New drug trial targets painful skin condition
NCT ID NCT07000630
Summary
This study tested whether the medication deucravacitinib helps control palmoplantar pustulosis, a skin condition causing painful blisters on hands and feet. About 25 adults with moderate-to-severe symptoms took the drug daily for four months. Researchers measured changes in skin symptoms and quality of life to see if the treatment was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PALMOPLANTAR PUSTULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University First Hospital
Beijing, 100034, China
Conditions
Explore the condition pages connected to this study.